dalteparin has been researched along with Abnormality, Heart in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saini, A | 1 |
| Cavalcante, R | 1 |
| Crisanto, LA | 1 |
| Sasaki, J | 1 |
| Zeina, AR | 1 |
| Nachtigal, A | 1 |
| Troitsa, A | 1 |
| Admon, G | 1 |
| Avshovich, N | 1 |
| Manlhiot, C | 1 |
| Brandão, LR | 1 |
| Kwok, J | 1 |
| Kegel, S | 1 |
| Menjak, IB | 1 |
| Carew, CL | 1 |
| Chan, AK | 2 |
| Schwartz, SM | 1 |
| Sivarajan, VB | 1 |
| Caldarone, CA | 1 |
| Van Arsdell, GS | 1 |
| McCrindle, BW | 1 |
| Streif, W | 1 |
| Goebel, G | 1 |
| Massicotte, MP | 1 |
| Bontadelli, J | 1 |
| Moeller, A | 1 |
| Schmugge, M | 1 |
| Schraner, T | 1 |
| Kretschmar, O | 1 |
| Bauersfeld, U | 1 |
| Bernet-Buettiker, V | 1 |
| Albisetti, M | 1 |
5 other studies available for dalteparin and Abnormality, Heart
| Article | Year |
|---|---|
Outcomes of Catheter-Related Arterial and Venous Thrombosis After Enoxaparin Therapy in Neonates and Infants With Congenital Heart Disease.
Topics: Anticoagulants; Catheters; Child; Enoxaparin; Heart Defects, Congenital; Humans; Infant; Infant, New | 2021 |
Isolated spontaneous dissection of the celiac trunk in a patient with bicuspid aortic valve.
Topics: Abdominal Pain; Anticoagulants; Aortic Dissection; Aortic Valve; Celiac Artery; Echocardiography, Tr | 2010 |
Thrombotic complications and thromboprophylaxis across all three stages of single ventricle heart palliation.
Topics: Anticoagulants; Cross-Sectional Studies; Enoxaparin; Female; Fontan Procedure; Heart Defects, Congen | 2012 |
Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients.
Topics: Anticoagulants; Antithrombin III; Catheters, Indwelling; Cohort Studies; Coronary Disease; Dose-Resp | 2003 |
Enoxaparin therapy for arterial thrombosis in infants with congenital heart disease.
Topics: Anticoagulants; Cardiac Catheterization; Cohort Studies; Coronary Thrombosis; Enoxaparin; Female; He | 2007 |